Dr Reddys Laboratories Share Price Today - Live Blog for April 11, 2025

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.25% increase and currently trading at ₹1,110.60 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd witnessed a -0.03% decrease in its share price, and it is currently trading at ₹1,108.25. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.0100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.02%, reaching a current market price of ₹1,120.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Demonstrating a commendable 0.13% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,120.00. In terms of valuation, the stock maintains a PE ratio of 17.0100, while the industry PE ratio stands at 31.9023.

Dr Reddys Laboratories Ltd observed a -0.08% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,122.55. The stock has a PE ratio of 17.0100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.08%, reaching a current market price of ₹1,122.55. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.04% increase and currently trading at ₹1,123.50 per share. This upward trajectory is turning heads in the market.

After a significant 0.01% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,123.65 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.01% boost, with the current market value at ₹1,123.65 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.18% drop, and it's now trading at ₹1,118.10 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.11% upswing and is currently trading at ₹1,120.15, indicating strong market sentiment.

Dr Reddys Laboratories Ltd experienced a -0.08% downturn in its share price, and it's currently trading at ₹1,120.60. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd experienced a -0.08% slump and is currently trading at ₹1,120.60. While the stock maintains a PE ratio of 17.0100, the industry PE is 31.9023, raising questions about valuation.

Demonstrating a commendable 0.08% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,121.85. In terms of valuation, the stock maintains a PE ratio of 17.0100, while the industry PE ratio stands at 31.9023.

Dr Reddys Laboratories Ltd's share price has dropped by -0.08%, a development that warrants careful analysis. Presently trading at ₹1,120.05, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd experienced a -0.36% dip in its share price and is currently trading at ₹1,119.95. The stock has a PE ratio of 17.0100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Following a noteworthy 0.44% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,123.05. When it comes to valuation, this stock has a PE ratio of 17.0100, with the industry PE ratio at 31.9023.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,117.50. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.48%, reaching a current market price of ₹1,116.50. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares saw a decrease of -2.09%, reaching a current market price of ₹1,119.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.